Carolina Cannabinoid Collaborative Meeting
|IMPORTANT BROWSER INFORMATION|
This site will not work on Internet Explorer 8. Please download one of the preferred browsers:
This meeting highlights the cannabinoid research being conducted by top U.S. researchers in the field. Basic mechanisms of cannabinoid effects on the body, preclinical and clinical findings regarding therapeutic benefits, and preclinical and clinical findings regarding potential adverse effects, with a focus on abuse, will be covered. The morning speaker will be Dr. Yasmin Hurd of Mt. Sinai Hospital. She has done extensive preclinical and clinical research focused on the pharmacological effects of cannabinoids with a focus on substance abuse and addiction treatment. She will summarize much of her work in her talk entitled, "The Promises and Challenges of Cannabis: Neurobiological and Clinical Insights.” The Saturday evening speaker is Dr. Donald Abrams, Chief of Hematology-Oncology at Zuckerburg San Francisco General Hospital. Dr. Abrams has extensive experience studying the clinical utility of medical marijuana for palliative care in HIV/AIDS and cancer patients. During his talk he will share his experiences with clinical cannabis research and review results from clinical trials which he has been involved with.
October 29, 2016 Agenda
9:00 – 10:00 AM: The Promises and Challenges of Cannabis: Neurobiological and Clinical Insights
Yasmin Hurd, PhD
Director, Center for Addictive Disorders, Icahn School of Medicine at Mt. Sinai
New York, NY
8:00 – 9:00 PM: Medical Marijuana: Tribulations and Trials
Donald Abrams, MD
Chief of Hematology-Oncology, Zuckerberg San Francisco General Hospital
Professor of Clinical Medicine, University of California, San Francisco
San Francisco, CA
Sidney Kimmel Medical College at Thomas Jefferson University is accredited by the ACCME to provide continuing medical education for physicians. Sidney Kimmel Medical College at Thomas Jefferson University designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Jefferson College of Population Health is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education.
This knowledge based program (0079-9999-16-023-L04-P) is acceptable for 2.0 hours of continuing pharmacy education credit. Statements of Credit indicating hours/CEUs will be uploaded to CPE Monitor within 60 days following program for participants who complete this activity and submit required participant information, including evaluation, NABP # and DOB.
The Carolina Cannabinoid Collaborative Meeting targets physicians, pharmacists, scientists and clinicians who study the biochemical and physiological effects of cannabinoid compounds in current research and medical practice.
Upon completion of this activity the participant should be able to:
- Evaluate and determine using knowledge-based informed decisions on their participation in the PA medical cannabis program as a certified physician or pharmacist recommender.
- Apply scientific, evidence based information on medical cannabis in the treatment of a range of identified disorders.
- Discuss and recommend new state legislation on medical cannabis uses in medical practice in order to provide novel treatment options to qualifying patients.
All faculty at continuing educating activities for nurses, physicians and allied health professionals are required to disclose to the audience (1) any significant financial relationships with the manufacturer(s) of any commercial products, goods or services and (2) any unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in the course presentation materials. Jefferson Conflict of Interest resolution process may result in changes to the agenda.
- 2.00 ACPE
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Attendance